Feasibility of Treating Irradiated Bone with Intramedullary Delivered Autologous Mesenchymal Stem Cells

<table class="table-group" width="800px"><tr class="fig-image" id="a"><td><img alt="560257.fig.001a" src="https://static.hindawi.com/articles/bmri/volume-2011/560257/figures/560257.fig.001a.jpg"/></td></tr><tr class="fig-caption"><td align="center"><table><tr><td><b>(a) </b>Macroscopic images</td></tr></table></td></tr><tr class="fig-image" id="b"><td><img alt="560257.fig.001b" src="https://static.hindawi.com/articles/bmri/volume-2011/560257/figures/560257.fig.001b.jpg"/></td></tr><tr class="fig-caption"><td align="center"><table><tr><td><b>(b) </b>Scintigraphic images</td></tr></table></td></tr></table>

<table>Animal model of hindlimb irradiation.  (a) Examples of pictures showing alopecia of the hindlimb 3 months after irradiation at a monodose of 30 Gy. (b) Examples of scintigraphic imaging showing the decrease of bone <sup>99m</sup>Tc-HDP on the irradiated hindlimb 3 months after irradiation.</table>

BioMed Research International

fig1

Figure 1

Figure 1: Feasibility of Treating Irradiated Bone with Intramedullary Delivered Autologous Mesenchymal Stem Cells 